After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Midday Bell
Top 10
Winners & Losers
A series of clinical trials will test the combination of Bristol's Opdivo with Nektar's NKTR-214 in multiple tumor types.
Stocks end Monday's session sharply lower as Wall Street grows restless ahead of the first presidential debate.
Stocks hold near session lows by mid-afternoon Monday as Wall Street grows restless ahead of the first presidential debate.
Stocks are lower Monday as Wall Street's attention shifts to the looming presidential debate from central bank policy.
